The purpose of this prospective pilot study is to gather preliminary evidence evaluating spinal cord stimulation (SCS) as a potential therapy for the treatment of rigidity and painful spasms in patients with stiff person syndrome (SPS), a rare autoimmune neurological condition. The hypothesis is that SCS-mediated clinical improvement occurs through multi-modal mechanisms of action targeting several components of neuronal inhibitory signaling pathways in the spinal cord.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Pain Scores
Timeframe: Baseline
Pain Scores
Timeframe: Day 24
Michigan Body map
Timeframe: baseline
Michigan Body Map
Timeframe: up to day 10
Penn Spasm Frequency and Severity Scale
Timeframe: Baseline
Penn Spasm Frequency and Severity Scale
Timeframe: up to day 10
Pain Disability Index
Timeframe: Baseline
Pain Disability Index
Timeframe: up to Day 10
Pittsburgh Sleep Quality Index (PSQI)
Timeframe: Baseline
Pittsburgh Sleep Quality Index (PSQI)
Timeframe: up to Day 10
Fatigue Severity Scale (FSS) scores
Timeframe: baseline
Fatigue Severity Scale (FSS) scores
Timeframe: up to day 10
Patient Health Questionnaire-Depression
Timeframe: baseline
Patient Health Questionnaire-Depression
Timeframe: up to day 10
Generalized Anxiety Disorder
Timeframe: baseline
Generalized Anxiety Disorder
Timeframe: up to day 10
EuroQOL (EQ-5D-5L)
Timeframe: Baseline
EuroQOL (EQ-5D-5L)
Timeframe: up to Day 10